The Clinical Trials Office: How clinical research is made possible
Long before a study opens to participation, months (sometimes years) of careful planning, review, and coordination is happening behind the scenes. Much of this work happens quietly, out of public view, but it is essential to the integrity, safety, and success of clinical research.
At the Masonic Cancer Center, University of Minnesota, this responsibility sits with MCC’s Clinical Trials Office.
Where the Clinical Trials Office fits
Clinical research at MCC is a collective effort, built on close collaboration across teams with distinct but interconnected roles.
The Clinical Trials Office (CTO) is part of the Masonic Cancer Center and works alongside the Minnesota Cancer Clinical Trials Network (MNCCTN), within the broader research mission of the University of Minnesota.
The Masonic Cancer Center provides scientific leadership and drives discovery through high-impact cancer research. The Minnesota Cancer Clinical Trials Network focuses on rural access, connecting patients and communities across the state to research opportunities. The Clinical Trials Office supports the operational work required to turn research ideas into trials that are ready to be carried out.
The CTO is not a downstream or purely administrative function; it plays a central role in moving research forward. Its involvement begins early, often at the moment a research question starts to take shape, and continues through every stage of a trial’s life. In many ways, it is the connective tissue that allows clinical research to move from concept to reality.
What does the Clinical Trials Office do?
Every clinical trial rests on a foundation of careful planning, oversight, and coordination. The Clinical Trials Office provides that foundation.
Working alongside investigators and research teams, the CTO supports the many steps required to prepare a study for launch and to sustain it once it is underway. This includes staff helping shape study protocols, coordinating regulatory and compliance review, managing the complex process of study start-up, and overseeing trial operations as they progress.
Throughout a trial, the CTO ensures that data are collected and managed responsibly, that reporting requirements are met, and that safeguards designed to protect participants are upheld. Each of these elements is essential.
Rather than operating in isolation, the CTO’s work weaves through every phase of a trial, supporting the investigator so that research can proceed with clarity, consistency, and care.
How clinical trials really happen
From the outside, clinical trials can appear straightforward: a study opens, patients enroll, and results are generated. In reality, the process is far more complex.
Before a trial is shared with a single participant, extensive preparation has already taken place. Research teams must align on a precise scientific question based on years of pre-clinical development and testing, translate that question into a detailed protocol or research plan, complete multiple layers of regulatory review, and prepare study sites to meet strict ethical and operational standards. Safeguards must be established to protect participants, and systems must be in place to ensure accuracy, transparency, and accountability.
The Clinical Trials Office is involved throughout this process, helping coordinate timelines, navigate regulatory requirements, and support the infrastructure that allows teams to work effectively together. Much of this work happens behind the scenes, but it is what allows trials to open with confidence.
Why this work matters
Breakthroughs in cancer research depend on more than innovative ideas. They depend on trust—trust that studies are conducted ethically, that participants are protected, and that results can be relied upon.
The Clinical Trials Office team upholds that trust. By strengthening the systems that support clinical research, CTO staff ensures that trials are conducted with rigor, transparency, and care. Their work protects patients, supports investigators, and helps translate discovery into advances in cancer prevention, detection, and treatment.
Strong infrastructure may not always be visible, but it is essential to meaningful impact.
Understanding how clinical trials are made possible provides important context for exploring the research itself. In the months ahead, we will highlight specific areas of cancer research supported through the Clinical Trials Office and show how this foundational work translates into studies designed to address real patient needs. Sign up for our monthly e-newsletter to stay in the loop!